Depo Medroxyprogesterone Acetate (DMPA): Long-Term Effects on Menstrual Cycle Disorders

نویسندگان

چکیده

bjective: To determine the effect of duration using Depo Medroxyprogesterone Acetate (DMPA) on Menstrual Cycle.Methods: This research is an analytical study 102 patients who used DMPA for less than 1 year and more then analyzed types menstrual disorders experienced while contraception at RSIA Masyita Makassar Tahun 2022. Data collection was carried out by direct observation RSIA. arranged in a checklist that has been prepared.Data processed SPSS version 25.0. Results: There significant between length use Cycle (p=0.000).Conclusion: are long-term effects cycle disorders, most common one hypermenorrhea. These results showed shown many Disorders hence can be midwives to provide knowledge counseling session wishes regarding side risks longer contraceptives.Keywords: (DMPA), use, cycle.AbstrakObjektif: Untuk mengetahui pengaruh lama penggunaan Medroksiprogesteron Asetat terhadap siklus menstruasi.Metode: Penelitian ini merupakan jenis penelitian analitik pasien yang menggunakan kurang dari tahun dan lebih kemudian dianalisis gangguan menstruasi dialami selama kontrasepsi di Makassar. Pengumpulan data dilakukan dengan metode observasi langsung disusun dalam telah disiapkan.Data diolah versi 25.0.Hasil: Ada signifikan antara (p=0,000).Kesimpulan: Adanya Efek Jangka Panjang Penggunaan Mentsruasi terbanyak yaitu Hipermenore. Hasil menunjukkan bahwaPenggunaan banyak efek pada selanjutnya dapat digunakan oleh bidan memberikan pengetahuan konseling kepada akan mengenai samping resiko lama.Kata kunci: pemakaian, menstruasi.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effects of Long-term Use of Depo-medroxyprogesterone Acetate on Lipid Metabolism in Nepalese Women

Various synthetic progestogens that are used as contraceptives have been reported to influence lipid and lipoprotein fractions differently. Depo-medroxyprogesterone acetate (DMPA), a synthetic progestogen, is used by Nepalese women as a contraceptive agent. Our study aims to determine the effects of long-term use of DMPA on lipid metabolism. We performed this study on 60 healthy Nepalese women ...

متن کامل

Subcutaneous depo-medroxyprogesterone acetate.

To cite: Cameron S. Journal of Family Planning and Reproductive Health Care 2013;39:75–77. INTRODUCTION Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe. As of March 2013 this product is being marketed in the UK as Sa...

متن کامل

Comparison of Sexual Dysfunction in Women Using Depo-Medroxyprogesterone Acetate (DMPA) and Cyclofem

BACKGROUND Sexual affairs are one of the physiological needs affecting human health. Sexual functioning disorders can reduce individual's capabilities and creativities. Sexual relations are in the center of women's quality of life. The most important family planning is to prevent unintended pregnancies. Injectable contraceptives protect women exposed to many complications and mortality due to u...

متن کامل

Uterine leiomyoma and its association with menstrual pattern and history of depo-medroxyprogesterone acetate injections

BACKGROUND AND AIM Despite the high prevalence of uterine leiomyoma, according to recent review studies there is uncertainty and a paucity of information regarding its predisposing or protective factors. The aim of this study was to assess the possible association between menstrual cycle pattern and occurrence of surgically treated myomas and also to check if depo-medroxyprogesterone acetate (D...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Indonesian Journal of Obstetrics and Gynecology

سال: 2023

ISSN: ['2338-6401', '2338-7335']

DOI: https://doi.org/10.32771/inajog.v11i2.1884